What top creators are saying about Dfinium Therapeutics(DFNM)
Biopharmaceutical company focusing on psychedelic treatments
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Dfinium Therapeutics.
Top creators covering Dfinium Therapeutics (DFNM)
The 1 sources with the most insights about Dfinium Therapeutics on Kazuha.
Latest insights about Dfinium Therapeutics (DFNM)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Today
Positive Phase 3 results for LSD-based depression treatment; upcoming psilocybin results in August are a potential catalyst.
Today
Positive Phase 3 results for LSD-based depression treatment; upcoming psilocybin results in August are a potential catalyst.
Discussed alongside Dfinium Therapeutics (DFNM)
Other assets that creators frequently mention in the same content as Dfinium Therapeutics.
Frequently asked
Which podcasters and creators cover Dfinium Therapeutics (DFNM) the most?
The most active sources covering Dfinium Therapeutics (DFNM) on Kazuha are Real Vision Podcast Network. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Dfinium Therapeutics (DFNM) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Dfinium Therapeutics (DFNM) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Dfinium Therapeutics (DFNM)?
Creators covering Dfinium Therapeutics (DFNM) most frequently also discuss MU, CL, GBP, UREA, GILT. See the "Discussed alongside" section above for full asset pages.